当前位置:首页 - 行情中心 - 江中药业(600750) - 财务分析 - 现金流量表

江中药业

(600750)

  

流通市值:136.75亿  总市值:138.43亿
流通股本:6.27亿   总股本:6.35亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,597,169,886.041,045,771,755.844,354,670,028.382,892,277,770.85
  收到的税费返还1,410,232.7241,786.83956,585.52956,585.52
  收到其他与经营活动有关的现金80,211,490.3448,095,944.12105,206,268.76127,679,961.48
  经营活动现金流入小计2,678,791,609.11,093,909,486.794,460,832,882.663,020,914,317.85
  购买商品、接受劳务支付的现金590,947,386.11230,671,799.131,109,066,821.27656,007,783
  支付给职工以及为职工支付的现金389,472,250.4207,750,006.08714,824,800.58525,760,467.16
  支付的各项税费353,581,625.77148,211,368.66533,430,518.24404,694,194.5
  支付其他与经营活动有关的现金693,002,671.55330,532,952.691,317,258,193.66991,490,980.51
  经营活动现金流出小计2,027,003,933.83917,166,126.563,674,580,333.752,577,953,425.17
  经营活动产生的现金流量净额651,787,675.27176,743,360.23786,252,548.91442,960,892.68
二、投资活动产生的现金流量:
  收回投资收到的现金747,000,000180,000,0001,230,150,000940,150,000
  取得投资收益收到的现金20,823,350.3717,309,222.3973,686,716.3470,157,568.47
  处置固定资产、无形资产和其他长期资产收回的现金净额46,968.119,603.4613,890,727.65157,413.64
  收到的其他与投资活动有关的现金--49,226,987.58-
  投资活动现金流入小计767,870,318.47197,328,825.851,366,954,431.571,010,464,982.11
  购建固定资产、无形资产和其他长期资产支付的现金108,039,700.646,907,046.41290,767,424.88148,075,935.32
  投资支付的现金987,854,031.58280,000,000995,217,555.12941,000,000
  取得子公司及其他营业单位支付的现金---1,000,000
  投资活动现金流出小计1,095,893,732.18326,907,046.411,285,984,9801,090,075,935.32
  投资活动产生的现金流量净额-328,023,413.71-129,578,220.5680,969,451.57-79,610,953.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金83,953,600---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计83,953,600---
  分配股利、利润或偿付利息支付的现金457,339,645.66-768,458,565.77446,191,944.18
  支付其他与筹资活动有关的现金1,441,453.158,080.0688,980,022.171,893,525.17
  筹资活动现金流出小计458,781,098.7658,080.06857,438,587.94448,085,469.35
  筹资活动产生的现金流量净额-374,827,498.76-58,080.06-857,438,587.94-448,085,469.35
五、现金及现金等价物净增加额-51,063,237.247,107,059.619,783,412.54-84,735,529.88
  加:期初现金及现金等价物余额651,924,308.69651,924,308.69642,140,896.15642,140,896.15
  期末现金及现金等价物余额600,861,071.49699,031,368.3651,924,308.69557,405,366.27
补充资料:
  净利润559,418,824.32-860,506,989.31-
  资产减值准备-9,673,397.62-16,072,851.21-
  固定资产和投资性房地产折旧62,753,296.08-116,075,444.59-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧62,753,296.08-116,075,444.59-
  无形资产摊销10,223,750.07-19,218,501.23-
  长期待摊费用摊销492,447.43-943,796.67-
  处置固定资产、无形资产和其他长期资产的损失-992.41--1,837,913.47-
  固定资产报废损失513,522.27-1,048,220.28-
  公允价值变动损失-681,003.71-8,626,804.43-
  财务费用-39,852,034.03--73,208,941.08-
  投资损失1,171,137.15-976,900-
  递延所得税-12,668,194.8--12,777,758.36-
  其中:递延所得税资产减少-11,632,507.66--10,551,369.01-
    递延所得税负债增加-1,035,687.14--2,226,389.35-
  存货的减少-19,098,526.69-10,820,849.64-
  经营性应收项目的减少198,884,945.43--326,866,702.65-
  经营性应付项目的增加-103,835,774.63-175,969,462.46-
  其他4,559,358.42-3,633,303.54-
  现金的期末余额600,861,071.49-651,924,308.69-
  减:现金的期初余额651,924,308.69-642,140,896.15-
  现金及现金等价物的净增加额-51,063,237.2-9,783,412.54-
公告日期2025-08-222025-04-262025-03-202024-10-26
审计意见(境内)标准无保留意见
TOP↑